Pilot Mobile Medical Unit Study for I'm Fully Empowered4Her
IFE4Her
IGHID 12227 - Pilot Mobile Medical Unit Study for I'm Fully Empowered4Her (IFE4Her) Intervention on HIV Pre-Exposure Prophylaxis (PrEP) Uptake by Women Living in Durham Housing Authority - Affiliated Communities (IFE4Her Pilot Study)
1 other identifier
interventional
35
1 country
1
Brief Summary
The overarching objective for the pilot study is to test the feasibility of using a mobile medical unit as a delivery mode combined with enhanced Pre-exposure Prophylaxis (PrEP) messaging to increase awareness of PrEP and access to PrEP medical services among women living in public housing.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 1, 2022
CompletedFirst Posted
Study publicly available on registry
December 9, 2022
CompletedStudy Start
First participant enrolled
April 18, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 11, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 11, 2023
CompletedAugust 15, 2025
August 1, 2025
8 months
December 1, 2022
August 14, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Intervention Acceptability - Mean Score of Satisfaction Questionnaire (range 1-5 with higher scores meaning greater satisfaction)
Perceived satisfaction with the intervention as assessed through survey items
Immediately post-mobile medical unit visit (assessed an average of 10 minutes post mobile medical unit visit)
Intervention Acceptability - Number of Completed PrEP Consultations
Number of mobile clinic clients completing a PrEP consultation with a study provider as recorded by study staff in service records
Immediately post-mobile medical unit visit (assessed an average of 10 minutes post mobile medical unit visit)
Intervention Acceptability Assessed Qualitatively
Perceived acceptability of the intervention as assessed in qualitative in-depth interviews with mobile clinic clients To gain deeper insights about the perceived acceptability of the intervention the investigators will ask participants in in-depth interviews about how they about different aspects of the intervention, including services provided and their delivery. Acceptability will be defined as a positive rating (and reason for that rating) of participant satisfaction with each aspect of the intervention.
3 months
Secondary Outcomes (4)
PrEP uptake - Number of PrEP Prescriptions Written in the Mobile Clinic
Immediately post-mobile medical unit visit (assessed an average of 10 minutes post mobile medical unit visit)
PrEP persistence -Proportion of Participants Receiving a PrEP Prescription Who Completed a Follow-Up visit and Received a Follow-Up PrEP Prescription
3 months
PrEP Consultation Requests - Number of PrEP Appointments Requested
Baseline
PrEP Consultation Uptake - Number of PrEP Consultations Completed
Immediately post-mobile medical unit visit (assessed an average of 10 minutes post mobile medical unit visit)
Study Arms (1)
Mobile Medical Unit
EXPERIMENTALParticipants utilizing the mobile medical unit will be offered an appointment with a university system healthcare provider to receive blood pressure check, blood glucose check, HIV testing and/or Pre-exposure Prophylaxis (PrEP) consultation.
Interventions
IFE4Her consists of 2 key components: 1) An awareness-raising messaging campaign with messages about PrEP that includes posters and Peer Networkers; and 2) access via a mobile medical unit outreach delivery model linking women in public housing to care from the PrEP providers of a university healthcare system and other complementary screening services (i.e., blood pressure, blood glucose monitoring, and HIV testing).
Eligibility Criteria
You may qualify if:
- years of age or older
- Identify as female
- Currently reside in Durham Housing Authority (DHA) housing
You may not qualify if:
- Currently on PrEP or Post-Exposure Prophylaxis (PEP)
- HIV-positive
- Being Male Gender
- Altered mental status precluding participant to provide informed consent
- Currently Pregnant or Trying to get Pregnant or Lactating.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of North Carolina, Chapel Hilllead
- Gilead Sciencescollaborator
- Duke Universitycollaborator
Study Sites (1)
University of North Carolina
Chapel Hill, North Carolina, 27514, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Carol Golin, MD
UNC-Chapel Hill
- PRINCIPAL INVESTIGATOR
Lauren Hill, PhD
UNC Chapel Hill
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 1, 2022
First Posted
December 9, 2022
Study Start
April 18, 2023
Primary Completion
December 11, 2023
Study Completion
December 11, 2023
Last Updated
August 15, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Beginning 9 months and continuing for 36 months following publication
- Access Criteria
- Investigator has approved IRB, IEC, or REB and an executed data use/sharing agreement with UNC.
Deidentified individual data that supports the results will be shared beginning 9 to 36 months following publication provided the investigator who proposes to use the data has approval from an Institutional Review Board (IRB), Independent Ethics Committee (IEC), or Research Ethics Board (REB), as applicable, and executes a data use/sharing agreement with UNC.